AcademicCME

Register TODAY for the Advanced Curriculum for MS Course, presented prior to CMSC 2026 & chaired by Fred Lublin, MD. This free CE event is both in-person and virtual on Tues, May 26 @ pm EDT @ the Charlotte Convention Center. For more info and to register, visit: academiccme.com/precmsc26. #CE #MS #Lublin #CMSC #APP

In a meta-analysis of 36 cohorts and 5.3 million people with type 2 diabetes, GLP‑1 RAs and SGLT2 inhibitors were each linked to ~20–25% lower risks of HCC and other liver-related events, while DPP‑4 inhibitors showed no hepatoprotection and were associated with higher rates of non-HCC liver complications. journals.lww.com/hep/abstract/9…

1) Welcome to a NEW CE-#accredited tweetorial from @womenshealth_CE! By following this 🧵you can earn 0.75hr 🆓CE and #CME from @academiccme ! This program is intended for #NPs and #PAs who work in women's health and our focus is on #pain 😰in #endometriosis.

17) Congratulations! 👏🥳You just earned 0.75hr 🆓 CE/#CME! Point your 🖱️to academiccme.com/womenshealth-t… to grab your certificate. Thank you 🙏 for joining us!

I really get excited about high-impact papers. This one is an instant classic. The investigators surveyed ~250 TBI survivors and ~250 TBI caregivers, an average of 12 years after the injury. They asked – what is the minimally acceptable outcome that is acceptible after severe TBI? Both survivors and care givers agreed –– recovery of yes/no communication is the basic common denominator. Being able to have any semblance of control about what happens to you. A basic human right, worth experiencing. So interesting. In my ICU end of life conversations moving forward, I am going to use "yes/no" and "following commands" in equal balance when descibing MCS/coma outcomes. Saying yes or no –– sounds a way lot better than following commands. #curingcoma @HarvardHealth @VUMCDiscoveries Perspectives of Persons With Lived Experience on Acceptable ... : Critical Care Medicine journals.lww.com/ccmjournal/abs…

The diagnosis of polymyalgia rheumatica is made on the basis of clinical grounds by combining characteristic signs and symptoms with laboratory findings and ruling out common mimickers such as late-onset rheumatoid arthritis and pseudogout, among others (seen in figure). Learn more: nejm.org/doi/full/10.10…

Excited to share a new accredited tweetorial from @cardiomet_ce! Latest 2026 data on #ATTR-CM, focusing on diagnosis and management with #TTR stabilizers. @academiccme cardiometabolic-ce.com/attr9/

21) And for now, point your 🖱️to cardiometabolic-ce.com/attr9/ and claim your 🆓ONE HOUR CE/#CME! Many thanks to our expert author, @HanCardiomd! #MedEd

16a) And the notable new data keep coming in in 2026! @KMAlexanderMD led this study of efficacy of #Acoramidis in wild-type vs variant #ATTRCM, published 🔓 pubmed.ncbi.nlm.nih.gov/41205147/. There is no heterogeneity across endpoints — early and sustained clinical benefit are clear.

11a) Take a look at 🔓 pubmed.ncbi.nlm.nih.gov/41528278/. 555 pts (315 ♀️), mean ± SD age 68.7±11.0. 3/5 had bilat sx. Biopsy procedure proved safe. Amyloid was ID'd in 216 (39%) cases (51% of ♂️ and 30% of ♀️ pts), more frequently in tenosynovial than transverse carpal ligament biopsies.

1) Welcome to a new #accredited #tweetorial and an update on #ATTR_CM examining the most interesting & important data published so far in 2026! We welcome new expert faculty Han Naung Tun (aka Henry Han) MD @HanCardiomd, #cardiologist Physician-Sci & Researcher #HeartFailure

1) Welcome to a NEW CE-#accredited tweetorial from @ce_womenshealth! By following this 🧵you can earn 0.75hr 🆓CE and #CME from @academiccme ! This program is intended for #NPs and #PAs who work in women's health and our focus is on #pain 😰in #endometriosis.

1) Welcome to a new #accredited #tweetorial from @ckd_ce & @cardiomet_ce, addressing new & exciting data released in 2025 on the first major advancement in #hypertension therapy in 20 years! We're talking about #aldosterone synthase inhibitors #ASI for difficult-to-control #HTN.

The signal linking GLP‑1 RAs with non‑arteritic anterior ischemic optic neuropathy #NAION: hazard ratios up to ~7 in retrospective cohorts, but absolute risk remains low and must be weighed against the substantial cardiometabolic benefits. academic.oup.com/jcem/article/1…

21) So, congratulations! 🥳🙌 You just earned 0.75hr 🆓 CE/#CME and you can claim it right now ⏱️at cardiometabolic-ce.com/hypertension5/! Thank you for joining us, please FOLLOW US for MORE #MedEd, and 🫡to our expert author @mvaduganathan!

1) Welcome to a new #accredited #tweetorial from @cardiomet_ce & @ckd_ce, addressing new & exciting data released in 2025 on the first major advancement in #hypertension therapy in 20 years! We're talking about #aldosterone synthase inhibitors #ASI for difficult-to-control #HTN.

25) And now you are UP TO DATE! Claim your 0.75hr 🆓CE/#CME at oncologytweetorials-ce.com/myelofibrosis2/ and FOLLOW US for more expert-authored #tweetorials right here on @onc_ce! Many thanks to @mpndoc this program!